Researchers described what they believe to be the first case of SMA type 4 presenting with a false enlargement of a muscle in ...

Women with spinal muscular atrophy (SMA) can experience successful pregnancies and give birth to healthy babies when ...

A test using a zebrafish model helped clinicians rule out SMA in two children, showing its potential use to clarify genetic ...

Columnist Jasmine Ramos explains her complicated feelings surrounding widespread coverage of a celebrity's SMA diagnosis ...

Columnist Sherry Toh details her recent visit to Universal Studios Singapore, where she noticed a gap between accessibility ...

Winter is columnist Connie Chandler's least favorite season, so her survival guide includes bundling up and large gatherings ...

A case report shows a baby with SMA met typical motor milestones at 10 months after a planned early C-section helped ...

For columnist Kevin Schaefer, the character arc of Dustin in "Stranger Things" is a reminder that feeling stuck is part of ...

Columnist Helen Baldwin recalls the surprising news of a new baby in the late 1990s, followed by a devastating SMA diagnosis.

FDA approved Itvisma, a one-time gene therapy for SMA patients ages 2 and older. Itvisma restores SMN protein, improving motor function and reducing treatment burden. A Novartis executive says the ...

SMA children frequently develop musculoskeletal problems such as scoliosis and hip dislocations, and new treatments are needed, per a study.

A gene therapy candidate extended survival in a mouse model of SMARD1, supporting its testing in a clinical trial for this rare form of SMA.